Inhibiting Leukocyte-endothelial Cell Interactions by Chinese Medicine Tongxinluo Capsule Alleviates No-reflow After Arterial Recanalization in Ischemic Stroke

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2023 May 1

PMID 37122157

Authors

Shen Liu

Zhaoxu Zhang

Yannan He

Lingbo Kong

Qiushuo Jin

Xiangjia Qi

Dahe Qi

Ying Gao

Affiliations

Soon will be listed here.

Abstract

Aims: Despite successful vascular recanalization in stroke, one-fourth of patients have an unfavorable outcome due to no-reflow. The pathogenesis of no-reflow is fully unclear, and therapeutic strategies are lacking. Upon traditional Chinese medicine, Tongxinluo capsule (TXL) is a potential therapeutic agent for no-reflow. Thus, this study is aimed to investigate the pathogenesis of no-reflow in stroke, and whether TXL could alleviate no-reflow as well as its potential mechanisms of action.

Methods: Mice were orally administered with TXL (3.0 g/kg/d) after transient middle cerebral artery occlusion. We examined the following parameters: neurological function, no-reflow, leukocyte-endothelial cell interactions, HE staining, leukocyte subtypes, adhesion molecules, and chemokines.

Results: Our results showed stroke caused neurological deficits, neuron death, and no-reflow. Adherent and aggregated leukocytes obstructed microvessels as well as leukocyte infiltration in ischemic brain. Leukocyte subtypes changed after stroke mainly including neutrophils, lymphocytes, regulatory T cells, suppressor T cells, helper T type 1 (Th1) cells, Th2 cells, B cells, macrophages, natural killer cells, and dendritic cells. Stroke resulted in upregulated expression of adhesion molecules (P-selectin, E-selectin, and ICAM-1) and chemokines (CC-chemokine ligand (CCL)-2, CCL-3, CCL-4, CCL-5, and chemokine C-X-C ligand 1 (CXCL-1)). Notably, TXL improved neurological deficits, protected neurons, alleviated no-reflow and leukocyte-endothelial cell interactions, regulated multiple leukocyte subtypes, and inhibited the expression of various inflammatory mediators.

Conclusion: Leukocyte-endothelial cell interactions mediated by multiple inflammatory factors are an important cause of no-reflow in stroke. Accordingly, TXL could alleviate no-reflow via suppressing the interactions through modulating various leukocyte subtypes and inhibiting the expression of multiple inflammatory mediators.

Citing Articles

Protective role of Tongxinluo in mitigating myocardial fibrosis in mice with acute myocardial infarction via neuregulin-1 upregulation and Inhibition of endothelium-interstitial transition.

Li Z, Yin Y, Wei Y, Liu Y, Han N, Wang X J Mol Histol. 2025; 56(2):103.

PMID: 40063284 PMC: 11893718. DOI: 10.1007/s10735-025-10378-7.

Zi Shen Wan Fang repaired blood-brain barrier integrity in diabetic cognitive impairment mice via preventing cerebrovascular cells senescence.

Yin Q, Yang G, Su R, Bu J, Li Y, Zhang H Chin Med. 2024; 19(1):169.

PMID: 39696612 PMC: 11657355. DOI: 10.1186/s13020-024-01041-6.

No-reflow after recanalization in ischemic stroke: From pathomechanisms to therapeutic strategies.

Sun F, Zhou J, Chen X, Yang T, Wang G, Ge J J Cereb Blood Flow Metab. 2024; 44(6):857-880.

PMID: 38420850 PMC: 11318407. DOI: 10.1177/0271678X241237159.

Emerging diagnostic markers and therapeutic targets in post-stroke hemorrhagic transformation and brain edema.

Yao Y, Liu F, Gu Z, Wang J, Xu L, Yu Y Front Mol Neurosci. 2024; 16:1286351.

PMID: 38178909 PMC: 10764516. DOI: 10.3389/fnmol.2023.1286351.

Inhibiting leukocyte-endothelial cell interactions by Chinese medicine Tongxinluo capsule alleviates no-reflow after arterial recanalization in ischemic stroke.

Liu S, Zhang Z, He Y, Kong L, Jin Q, Qi X CNS Neurosci Ther. 2023; 29(10):3014-3030.

PMID: 37122157 PMC: 10493667. DOI: 10.1111/cns.14242.

References

Vilela M, Lima G, Rodrigues D, Lacerda-Queiroz N, Mansur D, de Miranda A . TNFR1 plays a critical role in the control of severe HSV-1 encephalitis. Neurosci Lett. 2010; 479(1):58-62. DOI: 10.1016/j.neulet.2010.05.028. View

Liu S, Zhang Z, He Y, Kong L, Jin Q, Qi X . Inhibiting leukocyte-endothelial cell interactions by Chinese medicine Tongxinluo capsule alleviates no-reflow after arterial recanalization in ischemic stroke. CNS Neurosci Ther. 2023; 29(10):3014-3030. PMC: 10493667. DOI: 10.1111/cns.14242. View

Juli C, Heryaman H, Nazir A, Ang E, Defi I, Gamayani U . The Lymphocyte Depletion in Patients with Acute Ischemic Stroke Associated with Poor Neurologic Outcome. Int J Gen Med. 2021; 14:1843-1851. PMC: 8131088. DOI: 10.2147/IJGM.S308325. View

Stamatovic S, Phillips C, Keep R, Andjelkovic A . A novel approach to treatment of thromboembolic stroke in mice: Redirecting neutrophils toward a peripherally implanted CXCL1-soaked sponge. Exp Neurol. 2020; 330:113336. DOI: 10.1016/j.expneurol.2020.113336. View

Yu S, Cui W, Han J, Chen J, Tao W . Longitudinal change of Th1, Th2, and Th17 cells and their relationship between cognitive impairment, stroke recurrence, and mortality among acute ischemic stroke patients. J Clin Lab Anal. 2022; 36(7):e24542. PMC: 9280005. DOI: 10.1002/jcla.24542. View

Stanzione R, Forte M, Cotugno M, Bianchi F, Marchitti S, Rubattu S . Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease. Cell Mol Neurobiol. 2020; 42(3):545-556. PMC: 11441194. DOI: 10.1007/s10571-020-00966-4. View

Estevao C, Bowers C, Luo D, Sarker M, Hoeh A, Frudd K . CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium. Brain Behav Immun Health. 2021; 18:100370. PMC: 8560974. DOI: 10.1016/j.bbih.2021.100370. View

Offner H, Hurn P . A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Transl Stroke Res. 2012; 3(3):324-30. PMC: 3501272. DOI: 10.1007/s12975-012-0187-4. View

Joy S, Siddiqui K . Molecular and Pathophysiological Mechanisms of Diabetic Retinopathy in Relation to Adhesion Molecules. Curr Diabetes Rev. 2018; 15(5):363-371. DOI: 10.2174/1573399814666181017103844. View

10.

Liu N, Han J, Li Y, Jiang Y, Shi S, Lok J . Recombinant annexin A2 inhibits peripheral leukocyte activation and brain infiltration after traumatic brain injury. J Neuroinflammation. 2021; 18(1):173. PMC: 8353736. DOI: 10.1186/s12974-021-02219-7. View

11.

Hase Y, Okamoto Y, Fujita Y, Kitamura A, Nakabayashi H, Ito H . Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. Exp Neurol. 2011; 233(1):523-33. DOI: 10.1016/j.expneurol.2011.11.038. View

12.

Petrone A, Eisenman R, Steele K, Mosmiller L, Urhie O, Zdilla M . Temporal dynamics of peripheral neutrophil and lymphocytes following acute ischemic stroke. Neurol Sci. 2019; 40(9):1877-1885. PMC: 7898194. DOI: 10.1007/s10072-019-03919-y. View

13.

dos Santos A, Barsante M, Arantes R, Bernard C, Teixeira M, Carvalho-Tavares J . CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis--an intravital microscopy study. J Neuroimmunol. 2005; 162(1-2):122-9. DOI: 10.1016/j.jneuroim.2005.01.020. View

14.

Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T . Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med. 2009; 15(9):1031-7. DOI: 10.1038/nm.2022. View

15.

Bellavia S, Scala I, Rizzo P, Brunetti V, Broccolini A, Della Marca G . Th1/Th2 polarization of peripheral immune response in atherothrombotic and cardioembolic stroke: a prospective study. Sci Rep. 2022; 12(1):16384. PMC: 9525580. DOI: 10.1038/s41598-022-20515-x. View

16.

Ferro D, Matias M, Neto J, Dias R, Moreira G, Petersen N . Neutrophil-to-Lymphocyte Ratio Predicts Cerebral Edema and Clinical Worsening Early After Reperfusion Therapy in Stroke. Stroke. 2021; 52(3):859-867. DOI: 10.1161/STROKEAHA.120.032130. View

17.

Han D, Liu H, Gao Y . The role of peripheral monocytes and macrophages in ischemic stroke. Neurol Sci. 2020; 41(12):3589-3607. DOI: 10.1007/s10072-020-04777-9. View

18.

Luo Y, Zhou Y, Xiao W, Liang Z, Dai J, Weng X . Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response. Brain Res. 2014; 1597:86-94. DOI: 10.1016/j.brainres.2014.12.005. View

19.

Rodriguez-Perea A, Arcia E, Rueda C, Velilla P . Phenotypical characterization of regulatory T cells in humans and rodents. Clin Exp Immunol. 2016; 185(3):281-91. PMC: 4991523. DOI: 10.1111/cei.12804. View

20.

Chang L, Hu L, Wei C, Zhang H, Liu S . Chinese medicine Tongxinluo capsule protects against blood-brain barrier disruption after ischemic stroke by inhibiting the low-density lipoprotein receptor-related protein 1 pathway in mice. J Stroke Cerebrovasc Dis. 2020; 29(9):105071. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105071. View